EFDID: 470626EFD: View Filing

Issuer: Amalgam Rx, Inc. (0001667234) - D

Accession: 0001667234-23-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001667234
  • Entity Name:
    Amalgam Rx, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    1007 N. MARKET STREET
    SUITE 400
    WILMINGTON, DE 19801
  • Persons:
    Related Persons 3
    Ryan Sysko
    Executive Officer, Director
    Jeffrey Courtney
    Director
    Sonny Vu
    Director
EDGAR: Offering Information
  • Accession Date:
    01/03/2023
  • First Sale Date:
    12/16/2022
  • Offering Amount:
    $45,000,000
  • Amount Sold:
    $17,365,000
  • Amount Remaining:
    $27,635,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CA, CT, DC, DE, IN, MA, MD, NC, NH, NJ, NY, PA, TX, UT, VA
Inactive:IL, WA
EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Amalgam Rx, Inc.Ryan A. SyskoRyan A. SyskoChief Executive Officer2023-01-03